SKIN (SkinHealth Systems) Research & Development: $5.7 Mil (TTM As of Mar. 2026)


SKIN SkinHealth Systems Inc SKIN
49 GF Score
Price $0.66
GF Value $1.50
Valuation Possible Value Trap
! 4 Warning Signs
View Full Analysis

What is SkinHealth Systems Research & Development?

SkinHealth Systems SKIN +3.17% 49 Research & Development is $5.7 Mil as of Mar. 2026. GuruFocus rates SKIN with a GF Score™ of 49/100 and a GF Value™ of $1.50 (Possible Value Trap). The stock has 4 warning signs investors should review.

Research & Development is the aggregate amount of research and development expenses during the year. SkinHealth Systems's Research & Development for the three months ended in Mar. 2026 was $1.1 Mil. Its Research & Development for the trailing twelve months (TTM) ended in Mar. 2026 was $5.7 Mil.

SkinHealth Systems  (NAS:SKIN) Research & Development Explanation

If competitive advantage is created by a patent or tech advantage, at some point it will disappear.

High R&D usually dictates high SG&A which threatens the competitive advantage.

SkinHealth Systems Research & Development Related Terms

SkinHealth Systems Research & Development Historical Data

* Premium members only.

The historical data trend for SkinHealth Systems's Research & Development can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

SkinHealth Systems Research & Development Chart

SkinHealth Systems Annual Data
Trend Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Research & Development
Get a 7-Day Free Trial 8.20 8.44 10.10 6.30 5.63

SkinHealth Systems Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Research & Development Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1.00 1.25 1.70 1.68 1.10
SKIN
49GF Score
SkinHealth Systems Inc SKIN
Research & Development is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

SkinHealth Systems Research & Development Calculation

This is the expense the company spent on research and development.

Research & Development for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was $5.7 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Research & Development →
What does a Research & Development of $5.7 Mil mean?
SkinHealth Systems (SKIN) has a Research & Development of $5.7 Mil as of Mar. 2026. Research and development expense is the total cost for research and development activities. View historical data on SkinHealth Systems and its competitors.
Is SkinHealth Systems' Research & Development too high?
SkinHealth Systems' current Research & Development is $5.7 Mil. Overall, SkinHealth Systems has a GF Score™ of 49/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does SkinHealth Systems' Research & Development compare to SLSN and GROV?
SkinHealth Systems' Research & Development of $5.7 Mil can be compared against companies in the Consumer Packaged Goods industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Research & Development for a Consumer Packaged Goods company?
A good Research & Development depends on the Consumer Packaged Goods industry context. However, Research & Development should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Research & Development mean?
A high Research & Development can signal that a stock is expensive relative to its fundamentals. Research and development expense is the total cost for research and development activities. View historical data on SkinHealth Systems and its competitors. SkinHealth Systems's current Research & Development is $5.7 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is SkinHealth Systems stock overvalued right now?
Based on GuruFocus' analysis, SkinHealth Systems (SKIN) is currently considered Possible Value Trap. The stock's GF Value™ is $1.50, compared to a current price of $0.66 — trading 55.9% below its estimated fair value. The current Research & Development is $5.7 Mil. SkinHealth Systems' overall GF Score™ is 49/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Research & Development calculated?
Research & Development is calculated from a company's financial statements. For SkinHealth Systems (SKIN), the current Research & Development is $5.7 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is SkinHealth Systems (SKIN) Overvalued in 2026?

Based on GuruFocus' analysis, SkinHealth Systems stock appears to be undervalued. The current stock price of $0.66 is trading 55.9% below its estimated GF Value™ of $1.50. GuruFocus considers SkinHealth Systems to be Possible Value Trap.

Key valuation signals for SKIN:

  • Research & Development: $5.7 Mil
  • GF Value™: $1.50 vs. price of $0.66 (55.9% below fair value)
  • GF Score™: 49/100 with 4 warning signs

No single metric tells the full story. See the SKIN stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

SkinHealth Systems Business Description

Other Exchanges V7A0:Germany
Address 2165 Spring Street, Long Beach, CA, USA, 90806
SkinHealth Systems Inc is a world-wide medical aesthetics company delivering an integrated ecosystem of clinically validated solutions designed to help consumers achieve superior skin health and support the success of providers. Its brands are Hydrafacial and SkinStylus.
49GF Score

Get the complete analysis for SKIN

Research & Development is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$0.66
Price
$1.50
GF Value